ImageneBio (IMA) Tax Provisions (2024 - 2025)

ImageneBio (IMA) posted Tax Provisions of -$100000.0 for Q3 2025, down 766.67% sequentially from $15000.0 in Q2 2025.

ImageneBio (IMA) Tax Provisions (2024 - 2025) Analysis & Trends

ImageneBio has reported Tax Provisions for 2 years, with the latest figure at -$100000.0 in Q3 2025.

Quarterly Tax Provisions changed N/A year-over-year to -$100000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $95000.0 (changed N/A YoY) and the FY2024 annual result came in at $152000.0, up 193.83% from the prior year.
Tax Provisions fell to -$100000.0 in Q3 2025 per IMA's latest filing, from $15000.0 in the prior quarter.
Over five years, Tax Provisions peaked at $152000.0 in Q4 2024 and troughed at -$100000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	ImageneBio	47.79 Mn	-87.56 Mn	-	-

Download Data